News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Faces Hundreds of Individual Fosamax Trials



9/4/2013 8:38:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A federal judge overseeing consolidated litigation against Merck & Co over jaw injuries allegedly caused by the osteoporosis drug Fosamax has ordered hundreds of cases be dispersed to courts across the country for trial. The decision by U.S. District Judge John Keenan in Manhattan marks an unusual and potentially costly development for Merck. Companies often find it easier to reach settlements in mass tort cases that are consolidated before one judge.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Pharmalot


comments powered by Disqus
Reuters
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES